| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.08 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.08 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.082 | 0.08 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |